Shilpa Gadgil, PhD

VP, Head of bioprocess development, Head of CDMO development

Enzene

Serina Filler

Group Clinical Director

Pennard Vets

David Marks

Partner

Holland & Knight

David Marks enjoys closing fast-paced, high-pressure deals by aligning economic interests on both sides of the transaction. His practice focuses on buy-side and sell-side private equity M&A, and he has extensive experience in healthcare and other industries. In recent years, Mr. Marks has played a key role in numerous middle-market healthcare transactions involving dental, dermatology, ophthalmology, optometry and optical, chiropractic and physical therapy, women's health, gastroenterology and other specialties.

Private equity clients, investors and sellers value his counsel in recapitalizations, add-on acquisitions and roll-ups. Additionally, Mr. Marks represents private equity firms, investors and privately held companies in sales of portfolio companies and investments involving PE acquirers. Clients benefit from his ability to bring deals to successful conclusions despite the challenges often posed by the complex financing structures and deadlines of private equity transactions.

Previously, Mr. Marks gained valuable experience as an associate in New York where he advised private equity firms, distressed businesses and major financial institutions in the design and implementation of sweeping operational and financial restructurings and M&A in some of the largest Chapter 11 cases in recent history.

Julian Barnes

Founder and CEO

BFS Network